A Database Study to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada
Clinical trial NCT02367222 · COMPLETED
Trial details
- NCT number
- NCT02367222
- Sponsor
- University of Manitoba
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-08-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.